GoodRx launches $662 million term loan B at SOFR plus 300-325 bps

By Sara Rosenberg

New York, Jan. 23 – GoodRx launched on Tuesday its $662 million seven-year term loan B with price talk of SOFR plus 300 basis points to 325 bps with a 0% floor and an original issue discount of 99.5, according to a market source.

The term loan has 101 soft call protection for six months, no CSA and amortization of 1% per annum, the source said.

Goldman Sachs Bank USA is the left lead arranger on the deal.

Commitments are due at 5 p.m. ET on Jan. 30, the source added.

Proceeds will be used to refinance an existing first-lien term loan due October 2025.

In addition, the company is looking to amend its revolving credit facility to extend the maturity date.

Silver Lake Partners and Francisco Partners are the sponsors.

GoodRx is a Santa Monica, Calif.-based consumer-focused digital health care platform.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.